C-MER MEDICAL (03309) sells 55% equity stake in Apollo to Mingda Glasses.

C-MER MEDICAL (03309) announced that on December 17, 2025, the company entered into an agreement with Mingda Eyewear, under which the company has agreed to transfer the shares for sale back to Mingda Eyewear, representing 55% of Apollo's total issued share capital. The transaction price is the cancellation and return of the 504.9 million RMB bonds previously issued by the company to Mingda Eyewear, and the company is released from all obligations under the bonds. After completion, Apollo will no longer be a non-wholly-owned subsidiary of the company, and the company will no longer hold any equity interests in Apollo. The announcement stated that the group has implemented several strategic initiatives, including focusing on ophthalmic services in Hong Kong and mainland China, as well as dental and medical services in Shenzhen. The sale is in line with the strategy of optimizing the internal resource utilization of the group.